Do you have a question about BioAFM? This article will tell you everything you need to know.
FDA grants fast track status to Rznomics’ RZ-001 drug for HCC
The drug is currently undergoing Phase Ib/IIa trials for hepatocellular carcinoma. Credit: SewCreamStudio/Shutterstock. The US Food and Drug Administration (FDA) has granted fast track designation